Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CARA |
---|---|---|
09:32 ET | 15092 | 0.62 |
09:34 ET | 9400 | 0.62949 |
09:36 ET | 1600 | 0.619 |
09:39 ET | 8619 | 0.6169 |
09:41 ET | 500 | 0.6112 |
09:45 ET | 200 | 0.615 |
09:48 ET | 580 | 0.62 |
09:50 ET | 1301 | 0.6273 |
09:52 ET | 721 | 0.6288 |
09:54 ET | 2000 | 0.621899 |
09:56 ET | 100 | 0.615 |
09:57 ET | 100 | 0.6219 |
09:59 ET | 100 | 0.615 |
10:01 ET | 800 | 0.615 |
10:03 ET | 5917 | 0.6179 |
10:06 ET | 100 | 0.615 |
10:08 ET | 818 | 0.6277 |
10:10 ET | 200 | 0.6279 |
10:12 ET | 1000 | 0.62 |
10:14 ET | 300 | 0.615 |
10:15 ET | 100 | 0.615 |
10:17 ET | 600 | 0.615 |
10:19 ET | 988 | 0.615 |
10:21 ET | 200 | 0.611 |
10:26 ET | 190 | 0.613 |
10:28 ET | 600 | 0.6286 |
10:30 ET | 246 | 0.6101 |
10:32 ET | 100 | 0.6101 |
10:33 ET | 98185 | 0.5859 |
10:35 ET | 2700 | 0.6071 |
10:37 ET | 150 | 0.61792 |
10:39 ET | 400 | 0.5889 |
10:42 ET | 2559 | 0.6151 |
10:44 ET | 1280 | 0.6 |
10:46 ET | 996 | 0.6 |
10:48 ET | 100 | 0.6 |
10:50 ET | 1050 | 0.6107 |
10:51 ET | 3831 | 0.5995 |
10:53 ET | 2300 | 0.59 |
10:55 ET | 1200 | 0.59 |
10:57 ET | 2500 | 0.5905 |
11:00 ET | 10500 | 0.59 |
11:02 ET | 689 | 0.5889 |
11:04 ET | 400 | 0.59 |
11:06 ET | 1607 | 0.586 |
11:08 ET | 2052 | 0.582 |
11:09 ET | 26557 | 0.577 |
11:11 ET | 401 | 0.571 |
11:13 ET | 300 | 0.57725 |
11:15 ET | 852 | 0.575 |
11:18 ET | 10397 | 0.576 |
11:20 ET | 21376 | 0.5857 |
11:22 ET | 2000 | 0.58735 |
11:24 ET | 1200 | 0.58735 |
11:27 ET | 100 | 0.58905 |
11:29 ET | 2465 | 0.5907 |
11:31 ET | 100 | 0.59335 |
11:33 ET | 3013 | 0.5972 |
11:36 ET | 1100 | 0.597774 |
11:38 ET | 100 | 0.5946 |
11:40 ET | 401 | 0.5946 |
11:44 ET | 200 | 0.591 |
11:45 ET | 200 | 0.59 |
11:47 ET | 100 | 0.59 |
11:49 ET | 100 | 0.59 |
11:51 ET | 377 | 0.5901 |
11:54 ET | 1729 | 0.589 |
11:56 ET | 994 | 0.589 |
11:58 ET | 100 | 0.5919 |
12:00 ET | 100 | 0.5877 |
12:02 ET | 200 | 0.5877 |
12:03 ET | 516 | 0.5874 |
12:05 ET | 200 | 0.5874 |
12:07 ET | 2532 | 0.58895 |
12:09 ET | 100 | 0.58895 |
12:12 ET | 1350 | 0.5874 |
12:14 ET | 245 | 0.58895 |
12:16 ET | 5885 | 0.58895 |
12:20 ET | 360 | 0.58895 |
12:21 ET | 1000 | 0.5887 |
12:23 ET | 8568 | 0.5905 |
12:25 ET | 2385 | 0.5918 |
12:27 ET | 10340 | 0.601 |
12:32 ET | 1764 | 0.601 |
12:34 ET | 1278 | 0.59575 |
12:36 ET | 405 | 0.5902 |
12:38 ET | 740 | 0.596 |
12:39 ET | 939 | 0.5901 |
12:41 ET | 219 | 0.5958 |
12:43 ET | 5862 | 0.6076 |
12:48 ET | 200 | 0.59885 |
12:50 ET | 500 | 0.6033 |
12:52 ET | 226 | 0.5989 |
12:54 ET | 317 | 0.6077 |
12:57 ET | 8275 | 0.5951 |
01:01 ET | 1139 | 0.595099 |
01:03 ET | 200 | 0.5926 |
01:06 ET | 1181 | 0.5985 |
01:08 ET | 292 | 0.5951 |
01:10 ET | 522 | 0.6 |
01:12 ET | 100 | 0.59775 |
01:15 ET | 280 | 0.6002 |
01:17 ET | 1273 | 0.595 |
01:19 ET | 200 | 0.595 |
01:26 ET | 750 | 0.59755 |
01:28 ET | 1528 | 0.6005 |
01:30 ET | 1900 | 0.600125 |
01:33 ET | 100 | 0.5951 |
01:35 ET | 600 | 0.598451 |
01:37 ET | 564 | 0.5979 |
01:42 ET | 15312 | 0.5975 |
01:44 ET | 327 | 0.5975 |
01:46 ET | 1384 | 0.5975 |
01:48 ET | 337 | 0.5975 |
01:50 ET | 2100 | 0.5999 |
01:55 ET | 506 | 0.5999 |
01:57 ET | 400 | 0.6003 |
02:00 ET | 100 | 0.5999 |
02:02 ET | 300 | 0.6004 |
02:04 ET | 400 | 0.6 |
02:08 ET | 312 | 0.5997 |
02:11 ET | 978 | 0.6 |
02:13 ET | 755 | 0.6 |
02:18 ET | 100 | 0.6 |
02:20 ET | 342 | 0.6021 |
02:22 ET | 689 | 0.6021 |
02:26 ET | 1549 | 0.6021 |
02:27 ET | 200 | 0.6 |
02:29 ET | 542 | 0.6 |
02:33 ET | 1000 | 0.6042 |
02:36 ET | 952 | 0.602898 |
02:38 ET | 333 | 0.6 |
02:40 ET | 4657 | 0.5952 |
02:42 ET | 200 | 0.59705 |
02:44 ET | 1658 | 0.5951 |
02:45 ET | 8620 | 0.5968 |
02:47 ET | 1075 | 0.5959 |
02:49 ET | 553 | 0.596001 |
02:51 ET | 1102 | 0.5959 |
02:54 ET | 100 | 0.59635 |
02:56 ET | 100 | 0.59635 |
02:58 ET | 100 | 0.59635 |
03:02 ET | 332 | 0.5961 |
03:03 ET | 5227 | 0.59605 |
03:05 ET | 6390 | 0.59655 |
03:07 ET | 400 | 0.5972 |
03:09 ET | 464 | 0.5976 |
03:12 ET | 640 | 0.59591 |
03:14 ET | 209 | 0.5973 |
03:16 ET | 767 | 0.6015 |
03:18 ET | 1862 | 0.595 |
03:21 ET | 200 | 0.59865 |
03:25 ET | 537 | 0.5962 |
03:27 ET | 6222 | 0.6016 |
03:30 ET | 100 | 0.595 |
03:32 ET | 1303 | 0.59615 |
03:34 ET | 965 | 0.5965 |
03:36 ET | 695 | 0.5963 |
03:38 ET | 952 | 0.59515 |
03:39 ET | 1450 | 0.598365 |
03:41 ET | 8770 | 0.6 |
03:43 ET | 5570 | 0.6 |
03:45 ET | 270 | 0.595 |
03:48 ET | 7603 | 0.6 |
03:50 ET | 4552 | 0.6001 |
03:52 ET | 873 | 0.6 |
03:54 ET | 500 | 0.6001 |
03:56 ET | 1062 | 0.5975 |
03:57 ET | 5396 | 0.5983 |
03:59 ET | 2699 | 0.5979 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cara Therapeutics Inc | 32.7M | -0.3x | --- |
ImmuCell Corp | 34.1M | -8.7x | --- |
Aadi Bioscience Inc | 42.6M | -0.7x | --- |
SQZ Biotechnologies Co | 1.3M | 0.0x | --- |
Viaderma Inc | 8.3M | 0.0x | --- |
Turnstone Biologics Corp | 60.8M | -0.7x | --- |
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. The program is comprised of two studies - KOURAGE 1 and KOURAGE 2, which are double-blind, placebo-controlled, eight-week studies with patients allowed to roll-over into open-label 52-week extensions. It has developed an IV formulation of difelikefalin, for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.7M |
---|---|
Revenue (TTM) | $16.9M |
Shares Outstanding | 54.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-2.26 |
Book Value | $1.05 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 1.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -729.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.